Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Axsome Therapeutics
Axsome Therapeutics
(AXSM)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Auvelity
Dextromethorphan
,
Bupropion
2022-08-18
2023-2040
Atrial fibrillation
,
Atrial flutter
,
Cardiac arrhythmias
,
Cough
,
Neurobehavioral manifestations
,
Sinusitis
,
Asthma
,
Common cold
,
Allergic rhinitis perennial
,
Urticaria
,
Vasomotor rhinitis
,
Whooping cough
,
Bronchitis
,
Pharyngitis
,
Laryngitis
,
Postoperative complications
,
Pain
,
Vomiting
,
Nausea
,
Anaphylaxis
,
Allergic conjunctivitis
,
Motion sickness
,
Tobacco use disorder
,
Attention deficit disorder with hyperactivity
,
Depressive disorder
,
Juvenile arthritis
,
Ankylosing spondylitis
,
Rheumatoid arthritis
,
Headache
,
Fever
,
Inflammation
,
Osteoarthritis
,
Bursitis
,
Back pain
,
Toothache
,
Dysmenorrhea
,
Gout
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Rizatriptan
migraine disorders
,
headache
,
epilepsy
,
recurrence
Dextromethorphan
respiratory tract infections
,
common cold
Bupropion
healthy volunteers/patients
,
depression
,
depressive disorder
,
tobacco use disorder
,
overweight
,
body weight
,
type 2 diabetes mellitus
,
diabetes mellitus
,
obesity
,
cardiovascular diseases
Meloxicam
inflammation
Bupropion hydrochloride
healthy volunteers/patients
,
depression
,
depressive disorder
,
tobacco use disorder
,
overweight
,
body weight
,
type 2 diabetes mellitus
,
diabetes mellitus
,
obesity
,
cardiovascular diseases
Glutamic acid
diabetes mellitus
,
type 1 diabetes mellitus
,
healthy volunteers/patients
,
schizophrenia
,
prostatic neoplasms
,
castration-resistant prostatic neoplasms
,
adenocarcinoma
,
non-small-cell lung carcinoma
,
atrial fibrillation
Doconexent
hypogonadism
Esreboxetine
healthy volunteers/patients
,
pain
,
urinary incontinence
,
stress urinary incontinence
,
enuresis
,
depression
,
major depressive disorder
,
depressive disorder
,
neuralgia
,
postherpetic neuralgia
,
hyperkinesis
,
attention deficit disorder with hyperactivity
,
diabetic neuropathies
,
peripheral nervous system diseases
,
fibromyalgia
,
myofascial pain syndromes
,
hyperalgesia
,
obesity
,
alcoholism
Reboxetine
fecal incontinence
,
substance-related disorders
,
amphetamine-related disorders
,
mood disorders
,
urinary incontinence
,
stress urinary incontinence
,
enuresis
,
neuralgia
,
postherpetic neuralgia
,
hyperkinesis
,
attention deficit disorder with hyperactivity
,
sleepiness
,
diabetic neuropathies
,
peripheral nervous system diseases
,
post-traumatic stress disorders
,
traumatic stress disorders
,
obstructive sleep apnea
,
sleep apnea syndromes
,
apnea
,
fibromyalgia
,
narcolepsy
,
cataplexy
,
disorders of excessive somnolence
,
myofascial pain syndromes
,
dementia
,
psychophysiologic disorders
,
anxiety disorders
,
somatoform disorders
,
fatigue
,
pain
,
depression
,
major depressive disorder
,
depressive disorder
,
schizophrenia
,
abdominal pain
,
hypersensitivity
,
stroke
,
panic disorder
,
healthy volunteers/patients
,
hypoglycemia
,
decision making
,
obesity
,
alcoholism
D-glutamate
healthy volunteers/patients
Buproprion
healthy volunteers/patients
,
bipolar disorder
,
binge drinking
,
second primary neoplasms
,
addictive behavior
,
alcoholism
,
non-small-cell lung carcinoma
,
lung neoplasms
,
mood disorders
,
hiv infections
,
substance-related disorders
,
smoking cessation
,
smoking
,
treatment-resistant depressive disorder
,
alzheimer disease
,
dementia
,
crohn disease
,
huntington disease
,
chorea
,
depressive disorder
,
major depressive disorder
,
depression
,
tobacco use disorder
Nicoderm
failure to thrive
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use